Marshall Wace
IART icon

Marshall Wace’s Integra LifeSciences IART Stock Holding History

Marshall Wace’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.28M Buy
349,737
+176,254
+102% +$2.46M 0.01% 1252
2026
Q1 		$1.63M Buy
+173,483
New +$1.9M ﹤0.01% 1892
2025
Q3 		– Sell
-39,988
Closed -$491K – 3099
2025
Q2 		$491K Buy
+39,988
New +$581K ﹤0.01% 2154
2024
Q2 		– Sell
-26,709
Closed -$947K – 2716
2024
Q1 		$947K Buy
26,709
+15,322
+135% +$613K ﹤0.01% 1680
2023
Q4 		$496K Sell
11,387
-25,583
-69% -$1.01M ﹤0.01% 1718
2023
Q3 		$1.41M Sell
36,970
-333,318
-90% -$14M ﹤0.01% 1375
2023
Q2 		$15.2M Buy
+370,288
New +$17.8M 0.03% 583
2022
Q1 		– Sell
-4,063
Closed -$272K – 3628
2021
Q4 		$272K Buy
+4,063
New +$275K ﹤0.01% 3060
2021
Q3 		– Sell
-28,856
Closed -$1.97M – 3200
2021
Q2 		$1.97M Buy
+28,856
New +$2.04M 0.01% 1433
2020
Q4 		– Sell
-12,603
Closed -$595K – 2007
2020
Q3 		$595K Buy
+12,603
New +$600K ﹤0.01% 1186
2020
Q2 		– Sell
-10,887
Closed -$486K – 1733
2020
Q1 		$486K Buy
+10,887
New +$571K ﹤0.01% 980
2019
Q4 		– Sell
-392,910
Closed -$23.6M – 1874
2019
Q3 		$23.6M Sell
392,910
-9,406
-2% -$560K 0.19% 125
2019
Q2 		$22.5M Buy
402,316
+211,100
+110% +$10.9M 0.18% 111
2019
Q1 		$10.7M Buy
191,216
+47,790
+33% +$2.43M 0.1% 241
2018
Q4 		$6.47M Buy
+143,426
New +$7.87M 0.07% 376
2015
Q4 		– Sell
-18,590
Closed -$554K – 1041
2015
Q3 		$554K Sell
18,590
-5,500
-23% -$172K 0.01% 723
2015
Q2 		$663K Buy
+24,090
New +$642K 0.01% 671

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Marshall Wace's IART Position: Q2 2026 in Review

Marshall Wace increased its Integra LifeSciences (IART) stake by 102% in Q2 2026, buying an estimated $2.46M and bringing the position to 349,737 shares worth $6.28M. The position accounts for 0.01% of the portfolio, ranked #1252.

Marshall Wace first reported a position in IART in Q2 2015 and has held it in 17 quarters since. The position peaked at $23.6M in Q3 2019. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Marshall Wace held 349,737 shares of Integra LifeSciences worth $6.28M as of Q2 2026.
  • Marshall Wace bought 176,254 Integra LifeSciences shares in Q2 2026, an estimated $2.46M.
  • Integra LifeSciences made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #1252 holding.
  • Marshall Wace first reported a position in Integra LifeSciences in Q2 2015 and has held it in 17 quarters since.
  • Marshall Wace's Integra LifeSciences position peaked at $23.6M in Q3 2019.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.